CN106692932A - 口服液 - Google Patents

口服液 Download PDF

Info

Publication number
CN106692932A
CN106692932A CN201710021134.5A CN201710021134A CN106692932A CN 106692932 A CN106692932 A CN 106692932A CN 201710021134 A CN201710021134 A CN 201710021134A CN 106692932 A CN106692932 A CN 106692932A
Authority
CN
China
Prior art keywords
parts
oral liquid
ginger
raw materials
following raw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710021134.5A
Other languages
English (en)
Inventor
葛龙海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710021134.5A priority Critical patent/CN106692932A/zh
Publication of CN106692932A publication Critical patent/CN106692932A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明提供了一种口服液,是由下列重量份的原料制成:蜂王浆10~20份、L‑苹果酸5~10份、柠檬酸5~10份、维生素B220~30份、生姜10~20份。本发明提供的口服液行气活血、化瘀通络,打通全身经脉,高效安全无毒。

Description

口服液
技术领域
本发明属于中药技术领域,具体涉及口服液。
背景技术
冠心病、中风、偏瘫、高血压、高血脂、高血糖等疾病是常见病和慢性病,目前还没有特别有效的药方。
发明内容
根据上述阐述,本发明的目的在于提供一种对冠心病、中风、偏瘫、高血压、高血脂、高血糖有效治疗的药方。
本发明提供的技术方案:口服液,是由下列重量份的原料制成:
蜂王浆10~20份、L-苹果酸5~10份、柠檬酸5~10份、维生素B220~30份、生姜10~20份。
在上述技术方案中,是由下列重量份的原料制成:
蜂王浆15份、L-苹果酸8份、柠檬酸7份、维生素B225份、生姜15份。
本发明行气活血、化瘀通络,打通全身经脉,高效安全无毒。
具体实施方式
下面对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供的口服液是由下列重量份的原料制成:
蜂王浆10~20份、L-苹果酸5~10份、柠檬酸5~10份、维生素B2 20~30份、生姜10~20份。
本发明公开以下实施例。
实施例1:
口服液,是由下列重量份的原料制成:
蜂王浆15份、L-苹果酸8份、柠檬酸7份、维生素B2 25份、生姜15份。
实施例2:
口服液,是由下列重量份的原料制成:
蜂王浆20份、L-苹果酸10份、柠檬酸10份、维生素B2 20份、生姜10份。
实施例3:
口服液,是由下列重量份的原料制成:
蜂王浆10份、L-苹果酸5份、柠檬酸5份、维生素B2 30份、生姜20份。
本发明主要作用:行气活血、化瘀通络,打通全身经脉,用于冠心病、中风、偏瘫、高血压、高血脂、高血糖、高血液粘稠、痛风、颈腰椎病、脂肪肝、身体肥胖、微循环障碍等,高效安全无毒。
用法用量:口服,一般每日一次,每次30ml。
为表明本发明的应用效果,本发明经临床实验研究证明:
1、某男31岁,中风,一个疗程30天即症状变小,两个疗程即症状消失。
2、某女62岁,患有冠心病,连续本药一个月后,症状消失。
3、某男49岁,同时患有高血压、高血脂、高血糖,服药两个疗程后,症状基本缓解。
该药物共治疗上述冠心病、中风、偏瘫、高血压、高血脂、高血糖、高血液粘稠、痛风、颈腰椎病、脂肪肝、身体肥胖、微循环障碍等患者148例,治疗三十天后痊愈者62例,治疗六十日后痊愈者76例,有效率为93%。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。

Claims (2)

1.口服液,其特征在于:是由下列重量份的原料制成:
蜂王浆10~20份、L-苹果酸5~10份、柠檬酸5~10份、维生素B220~30份、生姜10~20份。
2.如权利要求1所述的口服液,其特征在于:是由下列重量份的原料制成:
蜂王浆15份、L-苹果酸8份、柠檬酸7份、维生素B225份、生姜15份。
CN201710021134.5A 2017-01-11 2017-01-11 口服液 Pending CN106692932A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710021134.5A CN106692932A (zh) 2017-01-11 2017-01-11 口服液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710021134.5A CN106692932A (zh) 2017-01-11 2017-01-11 口服液

Publications (1)

Publication Number Publication Date
CN106692932A true CN106692932A (zh) 2017-05-24

Family

ID=58908296

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710021134.5A Pending CN106692932A (zh) 2017-01-11 2017-01-11 口服液

Country Status (1)

Country Link
CN (1) CN106692932A (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103610200A (zh) * 2013-12-12 2014-03-05 安徽唐人保健茶品有限公司 一种抗癌保健口服液及其制作方法
CN106215068A (zh) * 2016-08-25 2016-12-14 明光市昊昊蜂业有限公司 一种抗衰老蜂王浆口服液

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103610200A (zh) * 2013-12-12 2014-03-05 安徽唐人保健茶品有限公司 一种抗癌保健口服液及其制作方法
CN106215068A (zh) * 2016-08-25 2016-12-14 明光市昊昊蜂业有限公司 一种抗衰老蜂王浆口服液

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
孟昭泉: "《食物药物相宜相克大全》", 30 June 2007, 金盾出版社 *
董捷: "《蜂蜜蜂王浆加工技术》", 31 July 2007, 金盾出版社 *

Similar Documents

Publication Publication Date Title
CN100382839C (zh) 一种治疗冠心病的中药组合物
CN102670928B (zh) 一种治疗颈椎病及腰椎病的膏药
CN103550636B (zh) 一种治疗荨麻疹的中药
CN1310664C (zh) 一种治疗心脑血管疾病的中药胶囊及其生产方法
CN106692932A (zh) 口服液
CN1970040A (zh) 治疗由动脉粥样硬化引起的高血压、糖尿病和冠心病的中药
CN103610831B (zh) 一种治疗颈肩痛的中药
CN103735630B (zh) 一种治疗痛风的中药
CN102552715B (zh) 中药组合物、含有该组合物的药物及其制备方法
CN102283925A (zh) 一种治疗带状疱疹引起的神经痛的中药
CN103536745A (zh) 一种治疗乳腺增生的中药水丸
CN104224990A (zh) 一种治疗高血压的中药
CN102813754B (zh) 一种治疗关节炎的中药膏药
CN103127413B (zh) 一种治疗冠心病的药物制剂
CN103083613A (zh) 一种治疗偏头痛的中药组合物
CN104800574A (zh) 一种治疗冠心病的中药制剂
CN101596297B (zh) 癣愈丸
CN100540043C (zh) 一种治疗高血压药物
CN103191326B (zh) 一种治疗冠心病的药物制剂
CN106074784A (zh) 治疗冠心病心肌缺血的中药
CN102068615B (zh) 一种治疗坐骨神经痛的中药液
CN101647925A (zh) 一种内服用于治疗坐骨神经痛的中药配方
CN104906320B (zh) 治疗强直性脊柱炎的中药制剂
CN104606578A (zh) 一种治疗药物引起的血栓性浅静脉炎的中药组合物
CN1190222C (zh) 治疗脑萎缩疾病的中药散剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170524

RJ01 Rejection of invention patent application after publication